https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / BJU Int. 2005 Oct;96(5):728-35
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / BJU Int. 2005 Oct;96(5):728-352005-10-01 00:00:002005-10-01 00:00:00The immunotherapy of prostate and bladder cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Cancer Biol. Ther. 2005 Oct;4(10):1144-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Cancer Biol. Ther. 2005 Oct;4(10):1144-532005-10-01 00:00:002019-02-15 08:35:08Synergistic interaction of hyperthermia and Gemcitabine in lung cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Mol. Carcinog. 2005 Oct;44(2):111-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Mol. Carcinog. 2005 Oct;44(2):111-212005-10-01 00:00:002019-02-15 08:35:09A mechanism of hyperthermia-induced apoptosis in ras-transformed lung cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Clin. Gastroenterol. Hepatol. 2005 Oct;3(10 Suppl 2):S78-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Clin. Gastroenterol. Hepatol. 2005 Oct;3(10 Suppl 2):S78-812005-10-01 00:00:002019-02-15 08:37:44Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Expert Opin Biol Ther 2005 Oct;5(10):1303-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Expert Opin Biol Ther 2005 Oct;5(10):1303-152005-10-01 00:00:002019-02-15 08:44:45Natural killer-dendritic cell cross-talk in cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-10-01 / Oncol. Rep. 2005 Oct;14(4):969-73
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-10-01 / Oncol. Rep. 2005 Oct;14(4):969-732005-10-01 00:00:002019-02-15 09:03:11Administration of dendritic cells in cancer nodules in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-09-28 / World J. Gastroenterol. 2005 Sep;11(36):5614-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-09-28 / World J. Gastroenterol. 2005 Sep;11(36):5614-202005-09-28 00:00:002019-02-15 09:03:09Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-09-27 / Cancer Immunol Immunother 2006 Jul;55(7):819-29
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-09-27 / Cancer Immunol Immunother 2006 Jul;55(7):819-292005-09-27 00:00:002005-09-27 00:00:00Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-09-26 / Clin. Immunol. 2006 Jan;118(1):66-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-09-26 / Clin. Immunol. 2006 Jan;118(1):66-762005-09-26 00:00:002019-02-15 09:25:38B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-09-01 / Leukemia 2005 Sep;19(9):1621-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-09-01 / Leukemia 2005 Sep;19(9):1621-72005-09-01 00:00:002019-02-15 08:45:56Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
